Jane Visvader
From Wikipedia, the free encyclopedia
Jane Visvader | |
|---|---|
 | |
| Alma mater | University of Adelaide |
| Scientific career | |
| Institutions | Walter and Eliza Hall Institute of Medical Research Salk Institute |
Jane Visvader is a scientist specialising in breast cancer research who works for the Walter and Eliza Hall Institute in Melbourne, Australia. She is the joint head of the Breast Cancer Laboratory with Geoff Lindeman.[1]
Visvader holds a PhD in Biochemistry from the University of Adelaide having studied structure and function of citrus exocortis viroid[2]
Career and research
After her PhD[3] in the Department of Biochemistry at the University of Adelaide , she was a postdoctoral researcher with Inder Verma (Salk Institute, San Diego) and Jerry Adams (Walter and Eliza Hall Institute (WEHI)).[4] She worked at the Children's Hospital/Harvard Medical School in Boston before returning to Victoria in 1997 to establish a Breast Cancer Laboratory at WEHI.[4]
Visvader has published work investigating the role of cells of origin in cancer[5] and in particular focuses on the role of stem cells,[6][7] which she believes may be a key to understanding breast cancer.[8] She was elected to the Australian Academy of Sciences in 2012 and is currently (January 2022 - December 2027) a member of the International Exchanges Committee.[9] The International Exchanges scheme allows a flexible platform for UK based scientists to interact with scientists around the world.
Visvader is a board member of the Cancer Council Victoria, Medical & Scientific Committee.[10]
Patents
Visvader is a named inventor on five patents relating to cancer research focused on stem cell isolation and diagnostics.[11]
- Method Of Cell Isolation, Application number: 20080038230
- Differentiation and/or proliferation modulating agents and uses therefor, Application number: 20060166917
- Novel phosphoprotein, Application number: 20060148032
- Method of diagnosis and treatment and agents useful for same, Application number: 20050048528
- Differentiation and/or proliferation modulating agents and uses therefore, Application number: 20030175971
